NEUROPACE, INC. (NPCE) Gross Margin
- Gross margin · 12 months: Value 77.38%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 77.38% | Gross profit / revenue. Period ending 2026-06-30. $82.79M ÷ $106.99M × 100 ≈ 77.38% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 82.79M USD | Gross Profit |
| Revenue | 106.99M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 24.20M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $82.79M | $106.99M | $24.20M | 77.38% |
| 2026-03-31 | $77.93M | $99.53M | $21.60M | 78.29% |
| 2025-12-31 | $77.22M | $99.99M | $22.77M | 77.23% |
| 2025-09-30 | $72.83M | $94.86M | $22.03M | 76.77% |
| 2025-06-30 | $67.08M | $88.57M | $21.49M | 75.74% |
| 2025-03-31 | $63.08M | $84.31M | $21.22M | 74.83% |
| 2024-12-31 | $59.09M | $79.91M | $20.82M | 73.94% |
| 2024-09-30 | $56.44M | $76.45M | $20.01M | 73.83% |
| 2024-06-30 | $53.26M | $71.82M | $18.56M | 74.15% |
| 2024-03-31 | $51.09M | $69.07M | $17.98M | 73.97% |
| 2023-12-31 | $48.12M | $65.42M | $17.30M | 73.56% |
| 2023-09-30 | $43.38M | $60.20M | $16.82M | 72.06% |
| 2023-06-30 | $39.11M | $54.93M | $15.82M | 71.21% |
| 2023-03-31 | $34.61M | $48.62M | $14.01M | 71.18% |
| 2022-12-31 | $32.49M | $45.52M | $13.03M | 71.38% |
| 2022-09-30 | $31.77M | $43.73M | $11.96M | 72.64% |
| 2022-06-30 | $31.31M | $42.91M | $11.60M | 72.96% |
| 2022-03-31 | $33.20M | $45.34M | $12.14M | 73.23% |
| 2021-12-31 | $33.44M | $45.18M | $11.75M | 74.00% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $30.27M | $41.14M | $10.87M | 73.59% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |